← Open Payments lookup

SHARON FELDMAN: Open Payments

NPI 1750534376 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$555 in 18 payments from 9 companies in 2025. Trend: 2023 $581 · 2024 $691 · 2025 $555

Food & beverage: $555
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$172
ABBVIE INC.2$161
Merck Sharp & Dohme LLC2$50
SOBI, INC1$43
Gilead Sciences, Inc.1$34
GlaxoSmithKline, LLC.1$30
Myriad Genetic Laboratories, Inc.2$29
Regeneron Healthcare Solutions, Inc.1$19
Ethicon US, LLC1$15

Products named: LYNPARZA, ELAHERE, Vonjo, Trodelvy, KEYTRUDA, JEMPERLI, MYRISK, LIBTAYO.

Industry payments across TX — which companies pay providers there.